{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-112123","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2025-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.105265+00:00","generated_at":"2026-05-16T18:54:34.781125+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Cadrenal Therapeutics files prospectus supplement for up to $3.4M ATM offering","bullets":["Filed prospectus supplement to sell up to $3,438,062 of common stock via ATM program with H.C. Wainwright.","As of Nov 18, 2025, $9,386,964 of common stock already sold under the same ATM agreement dated March 11, 2024.","Wainwright will receive 3.0% commission on gross sales; Company has no obligation to sell shares.","Legal opinion from Blank Rome LLP attached as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-112123","json":"https://secwatch.observer/filing/0001213900-25-112123.json","markdown":"https://secwatch.observer/filing/0001213900-25-112123.md","text":"https://secwatch.observer/filing/0001213900-25-112123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025112123/0001213900-25-112123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390025112123/ea0266097-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T18:54:34.781125+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}